
News|Articles|May 19, 2011
Sarcoma drug ridaforolimus may improve survival
LOS ANGELES (Reuters) - Ariad Pharmaceuticals' experimental cancer drug may improve overall survival in patients with advanced sarcoma, according to data from a phase III trial released Wednesday.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
A conversation about the consequences of Florida’s HIV medication cuts with Colleen Kelley, M.D., M.P.H., immediate past chair of the HIVMA and HIV specialist in Atlanta, Georgia
3
Oral Wegovy, uACR test spotlighted in the health-oriented Super Bowl ads
4
IRA price reductions to have little impact on future innovation, analysis finds
5

























